CNN has definately caught my eye today with the latest new...

CNN has definately caught my eye today with the latest new manufacturing JV and palnt announcement.

As posters have already stated why do CNN need another manufacturing palnt with one already in existence in China...as sales and supply must be in demand to meet manufacturing volumes.

From reading the last quartery and the rights issue well underwritten by pattersons at 1c i can't help that think a large contract can not be far off....please read this snippet from the last quarterly report as it does support such a view.
-----------------------------------------------------------
Development Projects with Major Brand Owners and Packaging Companies

Cardia has been extensively working on development projects with several local and international companies. Some of these projects are in commercial negotiations and others have advanced to ?in market trials?. These projects are under confidentiality agreements.

The Company is expecting these projects to convert into Sales Orders which in turn will contribute positively to the Company?s cash flow position and reduce the Company?s current cash burn. The number of these development projects is in excess of 30 and are being undertaken in various parts of the world. Whilst no assurances can be given as to the success of converting these projects from the development to commercial outcomes, any number of conversions would result in a substantial and positive effect on the Company?s sales.

Cardia is under confidential agreements with these global companies. However, Nestle has confirmed in a public release that they are working with Cardia and Cardia is their preferred renewable and sustainable bioplastics packaging partner. Again there is no assurance that
this relationship will lead to commercial outcomes.
Other major brand owners and packaging companies are currently progressing to in ?market trials and have ordered Cardia products accordingly. If these trials are successful, Cardia is expecting significant increase in sales from ?in-market trial orders? to ?commercial quantities? that will positively impact the cash flow of the Company.
-----------------------------------------------------------